Skip to content

Avanos Medical AVNS Free cash flow

Free cash flow at other companies

Stryker logo
StrykerSYK
$415M+227%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$56.84M+4.1%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%

Valuation

See full
Market cap$1.17B-1.2%
Enterprise value$1.24B+3.0%
P/S1.6×-0.1×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Calculated from Avanos Medical’s reported figures.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's free cash flow?
Avanos Medical (AVNS) reported free cash flow of -$16.6M in Q1 2026.
How has Avanos Medical's free cash flow changed year-over-year?
Avanos Medical's free cash flow decreased by 187.4% year-over-year, from $19M to -$16.6M.
What is the long-term trend for Avanos Medical's free cash flow?
Over 4 years (2021 to 2025), Avanos Medical's free cash flow has grown at a -8.1% compound annual growth rate (CAGR), from $66.3M to $47.3M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.